Safety, Selectivity, and Evidence Limitations

What the selectivity data shows and what it does not.

the selectivity question

The central safety claim for FOXO4-DRI is that it selectively kills senescent cells while leaving normal cells unharmed. This unit examines the evidence supporting that claim, identifies the gaps in the data, and outlines the theoretical risks that have not yet been tested.

Selectivity Comparison Chart

Visualize how FOXO4-DRI selectivity compares across cell types and senescence states.

selectivity comparison chart

Knowledge Check

Test your understanding of FOXO4-DRI selectivity evidence and its limitations.

Practice

Solidify the safety and evidence gap concepts before comparing senolytics.